Here are the key aspects of semaglutide: Mechanism of action: Semaglutide interacts with parts of the brain that regulate appetite, leading to reduced hunger and calorie intake It slows down digestion, allowing for a more gradual absorption of glucose and maintaining blood sugar levels Usage and brand names: For type 2 diabetes treatment, semaglutide is known as Ozempic and Rybelsus, with Rybelsus being the oral tablet form Under the brand name Wegovy, semaglutide is used specifically for chronic weight management in adults who are overweight or obese, with at least one weight-related health condition Dosage and administration: The typical dosage for weight loss is 2.4 milligrams once weekly as a subcutaneous injection For diabetes management, the dose may vary
For many patients, the convenience of a daily oral medication may outweigh the modest difference in weight-loss ceiling between the two formats
GLP-1 medications produce the opposite effect
When it crosses the blood-brain barrier and binds to c-Met, it initiates synaptogenesis: new dendritic spines form, synaptic connections strengthen, and neurons that were alive but under-connected begin to integrate more fully into functional networks